Publications

Our lab has produced seminal research on aging, epigenetics, and the development of non-invasive liquid biopsy-based biomarkers for the early detection of cancers. These papers underscore our commitment to advancing cancer research and improving patient care through innovative approaches.

Highlights include:

Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Cell PMID: 22439938
Aging and DNA methylation in colorectal mucosa and cancer Cancer Research PMID: 9850084
CpG island methylator phenotype in colorectal cancer PNAS PMID: 10411935

DNA-demethylating agents have a significant effect on tumor cells. Aging affects DNA methylation in colorectal mucosa and cancer. CpG island methylator phenotype is found in colorectal cancer. These findings contribute to the understanding of cancer development and progression, paving the way for innovative approaches in cancer research and patient care.

We are conducting research on how DNA-demethylating agents impact tumor cells. We are also exploring the relationship between aging and DNA methylation in colorectal cancer. Additionally, we are identifying CpG island methylator phenotype in colorectal cancer. These methods may result in new diagnostic and therapeutic strategies.

Publications

2024

Ventral hernia repair with permanent mesh for non-Hispanic black versus white patients: access and post-operative outcomes in the era of robotic surgeryChao G, Ying L, Huang L, Ma J, Ghiassi S, Gibbs K, Nadzam G, Morton J, Duffy A, Zhou R. Ventral hernia repair with permanent mesh for non-Hispanic black versus white patients: access and post-operative outcomes in the era of robotic surgery. Surgical Endoscopy 2024, 39: 560-567. PMID: 39433584, DOI: 10.1007/s00464-024-11252-5.
Current State of Endoscopic Bariatric TherapiesYing L, Butensky S, Ilang-Ying Y, Ghiassi S. Current State of Endoscopic Bariatric Therapies. Surgical Clinics Of North America 2024, 105: 159-171. PMID: 39523071, DOI: 10.1016/j.suc.2024.06.012.
Modern Management of Gastric Neuroendocrine NeoplasmsKunstman J, Nagar A, Gibson J, Kunz P. Modern Management of Gastric Neuroendocrine Neoplasms. Current Treatment Options In Oncology 2024, 25: 1137-1152. PMID: 39083164, DOI: 10.1007/s11864-024-01207-2.
Weight Nadir and Long-Term Weight Outcomes After Laparoscopic Sleeve Gastrectomy in a Diverse Cohort of Adolescents and Young AdultsHornick M, Chao G, Ying L, Nadzam G, Duffy A, Ghiassi S, Graetz E, Gibbs K, Morton J. Weight Nadir and Long-Term Weight Outcomes After Laparoscopic Sleeve Gastrectomy in a Diverse Cohort of Adolescents and Young Adults. Obesity Surgery 2024, 34: 2965-2973. PMID: 38935262, DOI: 10.1007/s11695-024-07374-3.
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision OncologyTan W, Nagabhyrava S, Ang-Olson O, Das P, Ladel L, Sailo B, He L, Sharma A, Ahuja N. Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology. Current Issues In Molecular Biology 2024, 46: 6533-6565. PMID: 39057032, PMCID: PMC11276574, DOI: 10.3390/cimb46070390.
Outcomes Following Implementation of an Electronic Model for Perioperative Hematologic ConsultationSu D, Rehman S, Wang K, Deng Y, Rose M, Dosani T, Kunstman J. Outcomes Following Implementation of an Electronic Model for Perioperative Hematologic Consultation. Journal Of Surgical Research 2024, 301: 10-17. PMID: 38905768, DOI: 10.1016/j.jss.2024.04.033.
American society for metabolic and bariatric surgery: intra-operative care pathway for minimally invasive Roux-en-Y gastric bypassLin H, Baker J, Meister K, Lak K, Martin Del Campo S, Smith A, Needleman B, Nadzam G, Ying L, Varban O, Reyes A, Breckenbridge J, Tabone L, Gentles C, Echeverri C, Jones S, Gould J, Vosburg W, Jones D, Edwards M, Nimeri A, Kindel T, Petrick A. American society for metabolic and bariatric surgery: intra-operative care pathway for minimally invasive Roux-en-Y gastric bypass. Surgery For Obesity And Related Diseases 2024, 20: 895-909. PMID: 39097472, DOI: 10.1016/j.soard.2024.06.002.
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision OncologyTan, Wan Ying, Snigdha Nagabhyrava, Olivia Ang-Olson, Paromita Das, Luisa Ladel, Bethsebie Sailo, Linda He, Anup Sharma, and Nita Ahuja. 2024. "Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology" Current Issues in Molecular Biology 46, no. 7: 6533-6565. https://doi.org/10.3390/cimb46070390
Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome AnalysisJohnson B, Teply B, Kagemann C, McGuire B, Lombardo K, Jing Y, Langbo W, Epstein J, Netto G, Baras A, Matoso A, McConkey D, Gupta A, Ahuja N, Ross A, Pierorazio P, Comperat E, Hoffman-Censits J, Singla N, Patel S, Kates M, Choi W, Bivalacqua T, Hahn N. Neoadjuvant Cisplatin, Gemcitabine, and Docetaxel in Sarcomatoid Bladder Cancer: Clinical Activity and Whole Transcriptome Analysis. Bladder Cancer 2024, 10: 133-143. PMID: 39131872, PMCID: PMC11308648, DOI: 10.3233/blc-240008.
Mo1492 EFFECTS OF THE HEALTH INSURANCE MARKETPLACE ON GASTROINTESTINAL CANCER SURGERY OUTCOMESButensky S, Kerekes D, Bakkila B, Kurbatov V, Kunstman J, Billingsley K, Khan S. Mo1492 EFFECTS OF THE HEALTH INSURANCE MARKETPLACE ON GASTROINTESTINAL CANCER SURGERY OUTCOMES. Gastroenterology 2024, 166: s-1891. DOI: 10.1016/s0016-5085(24)04833-9.
Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resectionYing L, Ilagan-Ying Y, Kunstman J, Peters N, Almeida M, Blackburn H, Ferrucci L, Billingsley K, Khan S, Chhoda A, John N, Salem R, Sharma A, Ahuja N. Prolonged length of stay and omission of adjuvant therapy are associated with early mortality after pancreatic adenocarcinoma resection. Surgical Oncology Insight 2024, 1: 100007. DOI: 10.1016/j.soi.2024.100007.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patientsLee V, Parkinson R, Zahurak M, Cope L, Cercek A, Verheul H, Gootjes E, Lenz H, Iqbal S, Jones P, Baylin S, Rami V, Ahuja N, Khoueiry A, Azad N. A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patients. International Journal Of Cancer 2024, 154: 1794-1801. PMID: 38312102, DOI: 10.1002/ijc.34845.
Abstract A072: Keratin 17-signature for stratification of chemotherapy in pancreatic adenocarcinomaChowdhury S, Yugawa D, Tseng R, Mejia M, Lacy J, Patel T, Escobar-Hoyos L, Shroyer K, Cai G, Robert M, Cecchini M, Kunstman J, Farrell J, Johung K. Abstract A072: Keratin 17-signature for stratification of chemotherapy in pancreatic adenocarcinoma. Cancer Research 2024, 84: a072-a072. DOI: 10.1158/1538-7445.panca2023-a072.
Outcomes of SADI and OAGB Compared to RYGB from the Metabolic and Bariatric Surgery Quality Improvement Program: The North American ExperienceChao G, Canner J, Hamid S, Ying L, Ghiassi S, Schwartz J, Gibbs K. Outcomes of SADI and OAGB Compared to RYGB from the Metabolic and Bariatric Surgery Quality Improvement Program: The North American Experience. Obesity Surgery 2024, 34: 337-346. PMID: 38170422, DOI: 10.1007/s11695-023-07019-x.

2023

Clinical predictive value of renalase in post-ERCP pancreatitisMuniraj T, Desir G, Gorelick F, Guo X, Ciarleglio M, Deng Y, Jamidar P, Farrell J, Aslanian H, Laine L. Clinical predictive value of renalase in post-ERCP pancreatitis. Gastrointestinal Endoscopy 2023, 99: 822-825.e1. PMID: 38103747, DOI: 10.1016/j.gie.2023.12.020.
The Degree of Preoperative Hypoalbuminemia Is Associated with Risk of Postoperative Complications in Metabolic and Bariatric Surgery PatientsYing L, Chao G, Canner J, Graetz E, Ghiassi S, Schwartz J, Zolfaghari E, Schneider E, Gibbs K. The Degree of Preoperative Hypoalbuminemia Is Associated with Risk of Postoperative Complications in Metabolic and Bariatric Surgery Patients. Obesity Surgery 2023, 34: 51-70. PMID: 37994997, DOI: 10.1007/s11695-023-06944-1.
Role of colectomy in the management of appendiceal tumors: a retrospective cohort studyMarks V, Kerekes D, Butensky S, Ahuja N, Johnson C, Turaga K, Khan S. Role of colectomy in the management of appendiceal tumors: a retrospective cohort study. BMC Gastroenterology 2023, 23: 398. PMID: 37978348, PMCID: PMC10655451, DOI: 10.1186/s12876-023-03019-4.
Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19Peters N, O'Connor R, Bhattacharya B, Kunstman J. Effects of novel Coronavirus (COVID-19) on presentation, management, and outcomes of acute cholecystitis at an academic tertiary care center cholecystitis management during COVID-19. Heliyon 2023, 9: e22043. PMID: 38027854, PMCID: PMC10658381, DOI: 10.1016/j.heliyon.2023.e22043.
S149 Can Pancreatic Cyst Detection Ratio Function as a Quality Indicator for EUS-Based Pancreatic Cancer Screening? A Systematic Review and Meta-AnalysisChhoda A, Woodbine M, Silva-Santisteban A, Grimshaw A, Gunderson C, Farrell J, Sawhney M. S149 Can Pancreatic Cyst Detection Ratio Function as a Quality Indicator for EUS-Based Pancreatic Cancer Screening? A Systematic Review and Meta-Analysis. The American Journal Of Gastroenterology 2023, 118: s115-s116. DOI: 10.14309/01.ajg.0000950236.60039.42.
S119 Disparities in Race, Ethnicity, Sex, and Age Inclusion in Pancreatic Cancer Screening Studies: A Systematic Review and Meta-AnalysisSilva-Santisteban A, Chhoda A, Woodbine M, Rabinowitz L, Grimshaw A, Farrell J, Sawhney M. S119 Disparities in Race, Ethnicity, Sex, and Age Inclusion in Pancreatic Cancer Screening Studies: A Systematic Review and Meta-Analysis. The American Journal Of Gastroenterology 2023, 118: s95-s99. DOI: 10.14309/01.ajg.0000950116.35207.91.
The Promise of Epigenetics Research in the Treatment of Appendiceal NeoplasmsLadel L, Tan W, Jeyakanthan T, Sailo B, Sharma A, Ahuja N. The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms. Cells 2023, 12: 1962. PMID: 37566041, PMCID: PMC10417136, DOI: 10.3390/cells12151962.
Impact of COVID-19 on the gastrointestinal surgical oncology patient populationBakkila B, Marks V, Kerekes D, Kunstman J, Salem R, Billingsley K, Ahuja N, Laurans M, Olino K, Khan S. Impact of COVID-19 on the gastrointestinal surgical oncology patient population. Heliyon 2023, 9: e18459. PMID: 37534012, PMCID: PMC10391949, DOI: 10.1016/j.heliyon.2023.e18459.
Surgical treatment of stage IV gastroenteropancreatic neuroendocrine carcinoma: Experience and outcomes in the United StatesKerekes D, Frey A, Bakkila B, Kunstman J, Khan S. Surgical treatment of stage IV gastroenteropancreatic neuroendocrine carcinoma: Experience and outcomes in the United States. Journal Of Surgical Oncology 2023, 128: 790-802. PMID: 37435780, DOI: 10.1002/jso.27392.
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal CancerCecchini M, Zhang J, Wei W, Sklar J, Lacy J, Zhong M, Kong Y, Zhao H, DiPalermo J, Devine L, Stein S, Kortmansky J, Johung K, Bindra R, LoRusso P, Schalper K. Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer. Cancer Research Communications 2023, 3: 1132-1139. PMID: 37387791, PMCID: PMC10305782, DOI: 10.1158/2767-9764.crc-23-0045.
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancerPeters G, Talcott W, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer. Journal Of Gastrointestinal Oncology 2023, 14: 1181-1192. PMID: 37435226, PMCID: PMC10331751, DOI: 10.21037/jgo-22-1005.
Sa1408 PREDICTIVE VALUE OF RENALASE IN POST-ERCP PANCREATITISMuniraj T, Desir G, Gorelick F, Guo X, Ciarleglio M, Deng Y, Jamidar P, Farrell J, Aslanian H, Laine L. Sa1408 PREDICTIVE VALUE OF RENALASE IN POST-ERCP PANCREATITIS. Gastroenterology 2023, 164: s-384-s-385. DOI: 10.1016/s0016-5085(23)01894-2.
76 ROLE OF COLECTOMY FOR APPENDICEAL TUMORSMarks V, Kerekes D, Ahuja N, Turaga K, Khan S. 76 ROLE OF COLECTOMY FOR APPENDICEAL TUMORS. Gastroenterology 2023, 164: s-1442. DOI: 10.1016/s0016-5085(23)04363-9.
Tu1001 ASSESSMENT IN TIME TO TREATMENT INITIATION AND SURVIVAL IN COLORECTAL CANCER FROM 2004-2017: ANALYSIS OF THE NATIONAL CANCER DATABASEKhatri R, Sharma A, John N, Ahuja N, Ehrlich A, Friedenberg F. Tu1001 ASSESSMENT IN TIME TO TREATMENT INITIATION AND SURVIVAL IN COLORECTAL CANCER FROM 2004-2017: ANALYSIS OF THE NATIONAL CANCER DATABASE. Gastroenterology 2023, 164: s-956. DOI: 10.1016/s0016-5085(23)03212-2.
A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancerBaretti M, Murphy A, Zahurak M, Gianino N, Parkinson R, Walker R, Lopez-Vidal T, Zheng L, Rosner G, Ahuja N, Kurt S, Azad N. A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer. Clinical Epigenetics 2023, 15: 74. PMID: 37120591, PMCID: PMC10149019, DOI: 10.1186/s13148-023-01485-x.
Early Detection of Cancers in the Era of Precision OncologyTan W, Sharma A, Das P, Ahuja N. Early Detection of Cancers in the Era of Precision Oncology. Current Opinion In Oncology 2023, 35: 115-124. PMID: 36721896, DOI: 10.1097/cco.0000000000000931.
Early Detection of Cancers in the Era of Precision OncologyWan Ying Tan, Anup Sharma, Paromita Das, Nita Ahuja (2023). Early Detection of Cancers in the Era of Precision Oncology. Curr Opin Oncol. 1;35(2):115-124. DOI: 10.1097/CCO.0000000000000931. PMID: 36721896 (Review article)
Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasmsChhoda A, Sharma A, Sailo B, Tang H, Ruzgar N, Tan W, Ying L, Khatri R, Narayanan A, Mane S, De Kumar B, Wood L, Iacobuzio-Donahue C, Wolfgang C, Kunstman J, Salem R, Farrell J, Ahuja N. Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms. Clinical Epigenetics 2023, 15: 28. PMID: 36803844, PMCID: PMC9942382, DOI: 10.1186/s13148-023-01429-5.
Comparison of Male and Female Surgeons’ Experiences With Gender Across 5 Qualitative/Quantitative DomainsZogg C, Kandi L, Thomas H, Siki M, Choi A, Guetter C, Smith C, Maduakolam E, Kondle S, Stein S, Shaughnessy E, Ahuja N. Comparison of Male and Female Surgeons’ Experiences With Gender Across 5 Qualitative/Quantitative Domains. JAMA Surgery 2023, 158: e226431. PMID: 36477515, PMCID: PMC9857060, DOI: 10.1001/jamasurg.2022.6431.
Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development.Tan W, Tian M, Ruzgar N, Hengartner A, Sailo B, Ang-Olson O, Ubas A, John N, Yaghoobi V, Tang H, Sharma A, Nalbantoglu I, Ahuja N. Use of distinct molecular signatures of appendiceal cancer subtypes to assess biomarker development. Journal Of Clinical Oncology 2023, 41: 189-189. DOI: 10.1200/jco.2023.41.4_suppl.189.

2022

A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceHeumann T, Baretti M, Sugar E, Durham J, Linden S, Lopez-Vidal T, Leatherman J, Cope L, Sharma A, Weekes C, O’Dwyer P, Reiss K, Monga D, Ahuja N, Azad N. A randomized, phase II trial of oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Clinical Epigenetics 2022, 14: 166. PMID: 36463226, PMCID: PMC9719150, DOI: 10.1186/s13148-022-01367-8.
Utilization and Outcomes of Radiation in Stage IV Esophageal CancerZhan P, Canavan M, Ermer T, Pichert M, Li A, Maduka R, Kaminski M, Johung K, Boffa D. Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer. JTO Clinical And Research Reports 2022, 3: 100429. PMID: 36483656, PMCID: PMC9722471, DOI: 10.1016/j.jtocrr.2022.100429.
The role of preoperative toxicology screening in patients undergoing bariatric surgeryChao G, Ying L, Chan S, Alturki N, Aravind P, Thaqi M, Mahmoud A, Morton J. The role of preoperative toxicology screening in patients undergoing bariatric surgery. Surgery For Obesity And Related Diseases 2022, 19: 187-193. PMID: 36443215, DOI: 10.1016/j.soard.2022.10.021.
Bile acid distributions, sex-specificity, and prognosis in colorectal cancerCai Y, Shen X, Lu L, Yan H, Huang H, Gaule P, Muca E, Theriot CM, Rattray Z, Rattray NJW, Lu J, Ahuja N, Zhang Y, Paty PB, Khan SA, Johnson CH. Bile acid distributions, sex-specificity, and prognosis in colorectal cancer. Biology Of Sex Differences 2022, 13: 61. PMID: 36274154, PMCID: PMC9590160, DOI: 10.1186/s13293-022-00473-9.
Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas CancerMokhtech M, Miccio JA, Johung K, Cecchini M, Stein S, Narang AK, Herman JM, Kunstman J, Haddock MG, Anker CJ, Jabbour S, Hallemeier CL, Jethwa KR. Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer. American Journal Of Clinical Oncology 2022, 45: 450-457. PMID: 36318696, DOI: 10.1097/coc.0000000000000947.
How Male and Female Surgeons’ Experiences with Gender in Surgery Compare: National Concurrent Mixed-Methods Survey of Fellows of the American College of SurgeonsZogg C, Kandi L, Thomas H, Siki M, Ahuja N. How Male and Female Surgeons’ Experiences with Gender in Surgery Compare: National Concurrent Mixed-Methods Survey of Fellows of the American College of Surgeons. Journal Of The American College Of Surgeons 2022, 235: s221-s222. DOI: 10.1097/01.xcs.0000894740.81658.e5.
S1453 Weight Loss in Bariatric Surgery Patients Treated at a Novel Clinic Incorporating Obesity Medicine for Treatment of Nonalcoholic Fatty Liver DiseaseIlagan-Ying Y, Schwartz A, Park E, Bollinger B, Ying L, Mehal W, Do A. S1453 Weight Loss in Bariatric Surgery Patients Treated at a Novel Clinic Incorporating Obesity Medicine for Treatment of Nonalcoholic Fatty Liver Disease. The American Journal Of Gastroenterology 2022, 117: e1043-e1044. DOI: 10.14309/01.ajg.0000862452.53915.0f.
Analyzing Resident Perceptions of Current Radiation Oncology Evaluation MethodsManjunath R, Rajeev-Kumar G, Tendulkar R, Corbin K, Johung K, Evans S, Shinohara E, Buckstein M, Pinnix C, Harkenrider M, Golden D, Hasan Y. Analyzing Resident Perceptions of Current Radiation Oncology Evaluation Methods. International Journal Of Radiation Oncology • Biology • Physics 2022, 114: e6. DOI: 10.1016/j.ijrobp.2022.06.007.
Access to telehealth services for colorectal cancer patients in the United States during the COVID-19 pandemicMarks VA, Hsiang WR, Umer W, Haleem A, Kim D, Kunstman JW, Leapman MS, Schuster KM. Access to telehealth services for colorectal cancer patients in the United States during the COVID-19 pandemic. The American Journal Of Surgery 2022, 224: 1267-1273. PMID: 35701240, PMCID: PMC9176198, DOI: 10.1016/j.amjsurg.2022.06.005.
Benefit of Extended Surveillance of Low-Risk Pancreatic Cysts After 5-Year Stability: A Systematic Review and Meta-AnalysisChhoda A, Singh S, Sheth AH, Grimshaw AA, Gunderson C, Sharma P, Kunstman JW, Sharma A, Ahuja N, Gonda TA, Farrell JJ. Benefit of Extended Surveillance of Low-Risk Pancreatic Cysts After 5-Year Stability: A Systematic Review and Meta-Analysis. Clinical Gastroenterology And Hepatology 2022, 21: 1430-1446. PMID: 35568304, DOI: 10.1016/j.cgh.2022.04.025.
Mo1131: HIGHLY SPECIFIC PROMOTER METHYLATION MARKERS FOR MALIGANT STRATIFICATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMSChhoda A, Sharma A, Tang H, Tan W, Sailo B, Peters N, Ying L, Ruzgar N, Kunstman J, Salem R, Farrell J, Ahuja N. Mo1131: HIGHLY SPECIFIC PROMOTER METHYLATION MARKERS FOR MALIGANT STRATIFICATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS. Gastroenterology 2022, 162: s-708. DOI: 10.1016/s0016-5085(22)61664-0.
Tu1185: DOES CURRENT EVIDENCE SUPPORT CYST GROWTH RATE AS A WORRISOME FEATURE? A SYSTEMATIC REVIEW AND META-ANALYSISSingh S, Chhoda A, Vodusek Z, Khatri R, Gunderson C, McCarty T, Sharma P, Grimshaw A, Kunstman J, Sharma A, Ahuja N, Gonda T, Farrell J. Tu1185: DOES CURRENT EVIDENCE SUPPORT CYST GROWTH RATE AS A WORRISOME FEATURE? A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology 2022, 162: s-907. DOI: 10.1016/s0016-5085(22)62148-6.
1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASEKhatri R, Chhoda A, Sharma A, Farrell J, Ahuja N, Ehrlich A, Friedenberg F. 1147: DISPARITIES IN TIME TO TREATMENT INITIATION IN COLORECTAL CANCER IN THE US FROM 2004-2018: ANALYSIS OF THE NATIONAL CANCER DATABASE. Gastroenterology 2022, 162: s-270-s-271. DOI: 10.1016/s0016-5085(22)60641-3.
A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better.Brubaker LS, Casciani F, Fisher WE, Wood AL, Cagigas MN, Trudeau MT, Parikh VJ, Baugh KA, Asbun HJ, Ball CG, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Fernandez-Del Castillo C, Dillhoff ME, Dixon E, House MG, Hughes SJ, Kent TS, Kunstman JW, Wolfgang CL, Zureikat AH, Vollmer CM, Van Buren G. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better. Surgery 2022, 171: 1058-1066. PMID: 34433515, DOI: 10.1016/j.surg.2021.07.026.
Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With SurgeryBakkila BF, Kerekes D, Nunez-Smith M, Billingsley KG, Ahuja N, Wang K, Oladele C, Johnson CH, Khan SA. Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery. JAMA Network Open 2022, 5: e225664. PMID: 35377425, PMCID: PMC8980937, DOI: 10.1001/jamanetworkopen.2022.5664.
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay JY, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty VG, Canter RJ, Mullen JT, Pennacchioli E, van Houdt W, Swallow CJ, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria SP. Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals Of Surgical Oncology 2022, 29: 4390-4390. PMID: 35307808, DOI: 10.1245/s10434-022-11600-6.
Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG).Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Rutkowski P, Blay JY, Strauss D, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Swallow CJ, Bagaria SP, Canter RJ, Mullen JT, Schrage Y, Pennacchioli E, van Houdt W, Cardona K, Fiore M, Gronchi A, Lahat G. Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG). Annals Of Surgical Oncology 2022 PMID: 35307809, DOI: 10.1245/s10434-022-11602-4.
Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut C, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay J, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty V, Canter R, Mullen J, Pennacchioli E, van Houdt W, Swallow C, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria S. Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals Of Surgical Oncology 2022, 29: 4391-4391. DOI: 10.1245/s10434-022-11601-5.
Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group.Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Annals Of Surgical Oncology 2022 PMID: 35301612, DOI: 10.1245/s10434-022-11599-w.
Less Is More: Lower Doses for Intermediate-Term Oropharyngeal ControlJohung KL, Park HS. Less Is More: Lower Doses for Intermediate-Term Oropharyngeal Control. International Journal Of Radiation Oncology • Biology • Physics 2022, 112: 585. PMID: 35101192, DOI: 10.1016/j.ijrobp.2021.07.1707.
Asparagine Metabolism in Tumors Is Linked to Poor Survival in Females with Colorectal Cancer: A Cohort StudyShen X, Cai Y, Lu L, Huang H, Yan H, Paty PB, Muca E, Ahuja N, Zhang Y, Johnson CH, Khan SA. Asparagine Metabolism in Tumors Is Linked to Poor Survival in Females with Colorectal Cancer: A Cohort Study. Metabolites 2022, 12: 164. PMID: 35208238, PMCID: PMC8875032, DOI: 10.3390/metabo12020164.
Abstract PO-155: Racial heterogeneity in the molecular landscape of pancreatic adenocarcinoma: A call for actionLarson H, Chhoda A, Hengartner A, Hasan N, Ruzgar N, Yalamanchi S, Kunstman J, Farrell J, Sharma A, Ahuja N. Abstract PO-155: Racial heterogeneity in the molecular landscape of pancreatic adenocarcinoma: A call for action. Cancer Epidemiology Biomarkers & Prevention 2022, 31: po-155-po-155. DOI: 10.1158/1538-7755.disp21-po-155.

2021

GCM2 Variants in Familial and Multiglandular Primary HyperparathyroidismVincze S, Peters NV, Kuo CL, Brown TC, Korah R, Murtha TD, Bellizzi J, Riccardi A, Parham K, Carling T, Costa-Guda J, Arnold A. GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism. The Journal Of Clinical Endocrinology & Metabolism 2021, 107: e2021-e2026. PMID: 34967908, DOI: 10.1210/clinem/dgab929.
Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control studyYaghoobi V, Moutafi M, Aung TN, Pelekanou V, Yaghoubi S, Blenman K, Ibrahim E, Vathiotis IA, Shafi S, Sharma A, O’Meara T, Fernandez AI, Pusztai L, Rimm DL. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case–control study. Breast Cancer Research 2021, 23: 113. PMID: 34906209, PMCID: PMC8670126, DOI: 10.1186/s13058-021-01493-w.
Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendationsChodoff A, Smith KC, Shukla A, Blackford AL, Ahuja N, Johnston FM, Peairs KS, Ngaiza JR, Warczynski T, Nettles B, Stotsky‐Himelfarb E, Murphy AG, Mayonado N, DeSanto J, Snyder CF, Choi Y. Colorectal cancer survivorship care plans: Variations in documentation and posttreatment surveillance recommendations. Journal Of Surgical Oncology 2021, 125: 678-691. PMID: 34894361, DOI: 10.1002/jso.26767.
Clinical outcomes of first line FOLFIRINOX vs . gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital SystemPatel T, Miccio J, Cecchini M, Srikumar T, Stein S, Kortmanksy J, Johung K, Lacy J. Clinical outcomes of first line FOLFIRINOX vs . gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System. Journal Of Gastrointestinal Oncology 2021, 0: 0-0. PMID: 35070386, PMCID: PMC8748034, DOI: 10.21037/jgo-21-202.
Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-AnalysisChhoda A, Vodusek Z, Wattamwar K, Mukherjee E, Gunderson C, Grimshaw A, Sharma A, Ahuja N, Kastrinos F, Farrell JJ. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis. Gastroenterology 2021, 162: 786-798. PMID: 34813861, DOI: 10.1053/j.gastro.2021.11.021.
Access to Colorectal Cancer Care for Medicaid-Insured Patients at Designated Cancer FacilitiesMarks VA, Hsiang WR, Umer W, Haleem A, Leapman MS, Kunstman JW, Schuster KM. Access to Colorectal Cancer Care for Medicaid-Insured Patients at Designated Cancer Facilities. Annals Of Surgical Oncology 2021, 29: 1518-1522. PMID: 34762215, DOI: 10.1245/s10434-021-11053-3.
Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal CancerPeters G, Wang S, Peters N, Dhanasopan A, Lacy J, Cecchini M, Kortmansky J, Stein S, Kunz P, Lattanzi S, Park H, Boffa D, Johung K, Jethwa K. Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e68. DOI: 10.1016/j.ijrobp.2021.07.422.
Preliminary Report Assessing Resident and Faculty Evaluations Across Radiation Oncology ProgramsRajeev-Kumar G, Manjunath R, Harkenrider M, Das P, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Shinohara E, Komarnicky L, Yeung A, Buckstein M, Golden D, Hasan Y. Preliminary Report Assessing Resident and Faculty Evaluations Across Radiation Oncology Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e191. DOI: 10.1016/j.ijrobp.2021.07.697.
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group.Bagaria SP, Swallow C, Suraweera H, Raut CP, Fairweather M, Cananzi F, Quagliuolo V, Grignani G, Hompes D, Ford SJ, Nessim C, Apte S, Skoczylas J, Rutkowski P, Bonvalot S, Tzanis D, Gabriel E, Pennacchioli E, Albertsmeier M, Canter RJ, Pollock R, Grignol V, Cardona K, Gamboa AC, Novak M, Stoeckle E, Almquist M, Ahuja N, Klemen N, Van Houdt W, Gyorki D, Gangi A, Rastrelli M, van der Hage J, Schrage Y, Valeri S, Conti L, Spiegel MR, Li Z, Fiore M, Gronchi A. Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group. Annals Of Surgical Oncology 2021, 28: 6882-6889. PMID: 33740198, DOI: 10.1245/s10434-021-09739-9.
The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis.Casciani F, Trudeau MT, Asbun HJ, Ball CG, Bassi C, Behrman SW, Berger AC, Bloomston MP, Callery MP, Christein JD, Falconi M, Fernandez-Del Castillo C, Dillhoff ME, Dickson EJ, Dixon E, Fisher WE, House MG, Hughes SJ, Kent TS, Kunstman JW, Malleo G, Partelli S, Wolfgang CL, Zureikat AH, Vollmer CM. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis. Surgery 2021, 170: 1195-1204. PMID: 33931208, DOI: 10.1016/j.surg.2021.03.044.
Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerYing L, Sharma A, Chhoda A, Ruzgar N, Hasan N, Kwak R, Wolfgang CL, Wang TH, Kunstman JW, Salem RR, Wood LD, Iacobuzio-Donahue C, Schneider EB, Farrell JJ, Ahuja N. Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer. Pancreas 2021, 50: 1267-1273. PMID: 34860810, DOI: 10.1097/mpa.0000000000001919.
S1030 Prevalence and Predictors of Musculoskeletal Disorders Amongst Nurses and Technicians Assisting in ERCPMbachi C, Jamidar P, Muniraj T, Farrell J, , Campbell E, Aslanian H. S1030 Prevalence and Predictors of Musculoskeletal Disorders Amongst Nurses and Technicians Assisting in ERCP. The American Journal Of Gastroenterology 2021, 116: s489-s489. DOI: 10.14309/01.ajg.0000777652.16974.b4.
Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinomaGao Y, Wang M, Guo X, Hu J, Chen TM, Finn S, Lacy J, Kunstman JW, H. C, Bellin MD, Robert ME, Desir GV, Gorelick FS. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma. PLOS ONE 2021, 16: e0250539. PMID: 34587190, PMCID: PMC8480607, DOI: 10.1371/journal.pone.0250539.
1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrenceHeumann T, Baretti M, Sugar E, Durhman J, Liden S, Miles T, Lopez-Vidal T, Leatherman J, Sharma A, Ahuja N, Weekes C, O'Dwyer P, Monga D, Binder K, Azad N. 1470P Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence. Annals Of Oncology 2021, 32: s1087-s1088. DOI: 10.1016/j.annonc.2021.08.797.
Analysis of Resident and Faculty Assessment Methods Used by United States Radiation Oncology Residency ProgramsRajeev-Kumar G, Manjunath R, Tendulkar R, Corbin K, Jagsi R, Marwaha G, Johung K, Evans S, Jawad M, Komarnicky-Kocher L, Shinohara E, Yeung A, Buckstein M, Das P, Harkenrider M, Golden D, Hasan Y. Analysis of Resident and Faculty Assessment Methods Used by United States Radiation Oncology Residency Programs. International Journal Of Radiation Oncology • Biology • Physics 2021, 111: e6-e7. DOI: 10.1016/j.ijrobp.2021.05.146.
Performing Bariatric Surgery on Previously COVID+ Patients Is Safe and EffectiveCheung MS, Ying L, Duffy AJ, Ghiassi S, Nadzam G, Roberts KE, Morton JM. Performing Bariatric Surgery on Previously COVID+ Patients Is Safe and Effective. Obesity Surgery 2021, 31: 5082-5084. PMID: 34453312, PMCID: PMC8396140, DOI: 10.1007/s11695-021-05659-5.
Immunotherapy Treatment for Triple Negative Breast CancerBerger ER, Park T, Saridakis A, Golshan M, Greenup RA, Ahuja N. Immunotherapy Treatment for Triple Negative Breast Cancer. Pharmaceuticals 2021, 14: 763. PMID: 34451860, PMCID: PMC8401402, DOI: 10.3390/ph14080763.
Epigenetic signatures differentiate uterine and soft tissue leiomyosarcomaHasan NM, Sharma A, Ruzgar NM, Deshpande H, Olino K, Khan S, Ahuja N. Epigenetic signatures differentiate uterine and soft tissue leiomyosarcoma. Oncotarget 2021, 12: 1566-1579. PMID: 34381562, PMCID: PMC8351604, DOI: 10.18632/oncotarget.28032.
Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trialSmith KC, White S, DeSanto J, Hannum S, Mayonado N, Ahuja N, Bowie J, Cowall D, Mischtschuk J, Peairs K, Thorner E, Tran P, Wolff A, Snyder C. Implementing survivorship care planning in two contrasting health systems: lessons learned from a randomized controlled trial. Journal Of Cancer Survivorship 2021, 16: 791-800. PMID: 34296383, DOI: 10.1007/s11764-021-01073-z.
Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015Cheng E, Blackburn H, Ng K, Spiegelman D, Irwin M, Ma X, Gross C, Tabung F, Giovannucci E, Kunz P, Llor X, Billingsley K, Meyerhardt J, Ahuja N, Fuchs C. Abstract 898: Survival for patients with early-onset colorectal cancer - An overall survival analysis from the National Cancer Database, 2004-2015. Cancer Research 2021, 81: 898-898. DOI: 10.1158/1538-7445.am2021-898.
ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut C, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay J, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty V, Canter R, Mullen J, Pennacchioli E, van Houdt W, Swallow C, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria S. ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals Of Surgical Oncology 2021, 28: 490-491. DOI: 10.1245/s10434-021-10095-x.
Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer DatabaseCheng E, Blackburn HN, Ng K, Spiegelman D, Irwin ML, Ma X, Gross CP, Tabung FK, Giovannucci EL, Kunz PL, Llor X, Billingsley K, Meyerhardt JA, Ahuja N, Fuchs CS. Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database. JAMA Network Open 2021, 4: e2112539. PMID: 34132794, PMCID: PMC8209612, DOI: 10.1001/jamanetworkopen.2021.12539.
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG).Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Rutkowski P, Blay JY, Strauss D, Gonzalez R, Ahuja N, Grignani G, Quagliuolo V, Stoeckle E, De Paoli A, Pillarisetty VG, Swallow CJ, Bagaria SP, Canter RJ, Mullen JT, Schrage Y, Pennacchioli E, van Houdt W, Cardona K, Fiore M, Gronchi A, Lahat G. Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG). Annals Of Surgical Oncology 2021, 28: 2705-2714. PMID: 33389288, DOI: 10.1245/s10434-020-09445-y.
Sa298 IS IT SAFE TO STOP SURVEILLANCE OF PANCREATIC CYSTS AFTER 5 YEARS OF STABILITY?: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CURRENT EVIDENCE.Chhoda A, Singh S, Sheth A, Sharma P, Sharma A, Kunstman J, Grimshaw A, Ahuja N, Farrell J. Sa298 IS IT SAFE TO STOP SURVEILLANCE OF PANCREATIC CYSTS AFTER 5 YEARS OF STABILITY?: A SYSTEMATIC REVIEW AND META-ANALYSIS OF CURRENT EVIDENCE. Gastroenterology 2021, 160: s-475. DOI: 10.1016/s0016-5085(21)01841-2.
Sa302 IS MULTIFOCALITY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS A RISK FACTOR FOR PANCREATIC MALIGNANCY?: A SYSTEMATIC REVIEW AND META-ANALYSISChhoda A, Singh S, Grimshaw A, Sheth A, Sharma A, Kunstman J, Ahuja N, Farrell J. Sa302 IS MULTIFOCALITY IN INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS A RISK FACTOR FOR PANCREATIC MALIGNANCY?: A SYSTEMATIC REVIEW AND META-ANALYSIS. Gastroenterology 2021, 160: s-477. DOI: 10.1016/s0016-5085(21)01845-x.
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Nessim C, Raut CP, Callegaro D, Barretta F, Miceli R, Fairweather M, Blay JY, Strauss D, Rutkowski P, Ahuja N, Gonzalez R, Grignani G, Quagliuolo V, Stoeckle E, Lahat G, De Paoli A, Pillarisetty VG, Canter RJ, Mullen JT, Pennacchioli E, van Houdt W, Swallow CJ, Schrage Y, Cardona K, Fiore M, Gronchi A, Bagaria SP. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG). Annals Of Surgical Oncology 2021, 28: 7854-7863. PMID: 33907921, DOI: 10.1245/s10434-021-10024-y.
COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individualsKatona BW, Mahmud N, Dbouk M, Ahmad N, Chhoda A, Dudley B, Hayat U, Kwon RS, Lee LS, Rustgi AK, Ukaegbu C, Vasquez L, Volk S, Brand RE, Canto MI, Chak A, Farrell JJ, Kastrinos F, Stoffel EM, Syngal S, Goggins M. COVID-19 related pancreatic cancer surveillance disruptions amongst high-risk individuals. Pancreatology 2021, 21: 1048-1051. PMID: 33926820, PMCID: PMC8055495, DOI: 10.1016/j.pan.2021.04.005.
Cystic Tumors Other than IPMNKunstman J, Farrell J. Cystic Tumors Other than IPMN. 2021, 608-623. DOI: 10.1002/9781119570097.ch74.
A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotypeBaretti M, Karunasena E, Zahurak M, Walker R, Zhao Y, Pisanic TR, Wang T, Greten TF, Duffy AG, Gootjes E, Meijer G, Verheul HMW, Ahuja N, Herman JG, Azad NS. A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype. Clinical And Translational Science 2021, 14: 954-963. PMID: 33811727, PMCID: PMC8212722, DOI: 10.1111/cts.12960.
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.Tempero MA, Malafa MP, Al-Hawary M, Behrman SW, Benson AB, Cardin DB, Chiorean EG, Chung V, Czito B, Del Chiaro M, Dillhoff M, Donahue TR, Dotan E, Ferrone CR, Fountzilas C, Hardacre J, Hawkins WG, Klute K, Ko AH, Kunstman JW, LoConte N, Lowy AM, Moravek C, Nakakura EK, Narang AK, Obando J, Polanco PM, Reddy S, Reyngold M, Scaife C, Shen J, Vollmer C, Wolff RA, Wolpin BM, Lynn B, George GV. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal Of The National Comprehensive Cancer Network : JNCCN 2021, 19: 439-457. PMID: 33845462, DOI: 10.6004/jnccn.2021.0017.
Publication Bias in Gastrointestinal Oncology Trials Performed over the Past DecadePeters GW, Tao W, Wei W, Miccio JA, Jethwa KR, Cecchini M, Johung KL. Publication Bias in Gastrointestinal Oncology Trials Performed over the Past Decade. The Oncologist 2021, 26: 660-667. PMID: 33728733, PMCID: PMC8342580, DOI: 10.1002/onco.13759.
Contemporary Experience of Posterior Retroperitoneoscopic Adrenalectomy in the USChiu A, Vargas-Pinto S, Abou-Azar S, Maduka R, Man J, Peters N, Carling T, Gibson C. Contemporary Experience of Posterior Retroperitoneoscopic Adrenalectomy in the US. Journal Of The American College Of Surgeons 2021, 232: 815-821. PMID: 33766728, DOI: 10.1016/j.jamcollsurg.2021.02.018.
Circumferential esophageal perforation resulting in tension hydropneumothorax in a patient with septic shockSaffo S, Farrell J, Nagar A. Circumferential esophageal perforation resulting in tension hydropneumothorax in a patient with septic shock. Acute And Critical Care 2021, 36: 264-268. PMID: 33691378, PMCID: PMC8435440, DOI: 10.4266/acc.2020.01067.
Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic RadiotherapyLi JY, D’Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S. Benefits of a Multidisciplinary Women’s Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy. American Journal Of Clinical Oncology 2021, 44: 143-149. PMID: 33755031, DOI: 10.1097/coc.0000000000000800.
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpointBever KM, Thomas DL, Zhang J, Diaz Rivera EA, Rosner GL, Zhu Q, Nauroth JM, Christmas B, Thompson ED, Anders RA, Judkins C, Liu M, Jaffee EM, Ahuja N, Zheng L, Azad NS. A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clinical Epigenetics 2021, 13: 25. PMID: 33531075, PMCID: PMC7856736, DOI: 10.1186/s13148-021-01014-8.
Managing Gallstone Disease in the Elderly.Chhoda A, Mukewar SS, Mahadev S. Managing Gallstone Disease in the Elderly. Clinics In Geriatric Medicine 2021, 37: 43-69. PMID: 33213774, DOI: 10.1016/j.cger.2020.08.005.
Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal AdenocarcinomaStrong JS, Vos EL, Mcintyre CA, Chou JF, Gonen M, Tang LH, Soares KC, Balachandran VP, Kingham TP, D'Angelica MI, Jarnagin WR, Drebin J, Kunstman JW, Allen PJ, Wei AC. Change in Neutrophil-to-Lymphocyte Ratio During Neoadjuvant Treatment Does Not Predict Pathological Response and Survival in Resectable Pancreatic Ductal Adenocarcinoma. The American Surgeon 2021, 88: 1153-1158. PMID: 33517697, PMCID: PMC8501834, DOI: 10.1177/0003134821989050.
Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPECIstl AC, Gage MM, Esquivel J, Ahuja N, Greer JB, Johnston FM. Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC. Annals Of Surgical Oncology 2021, 28: 3831-3837. PMID: 33393023, DOI: 10.1245/s10434-020-09312-w.

2020

Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysisMiccio JA, Talcott WJ, Patel T, Park HS, Cecchini M, Salem RR, Khan SA, Stein S, Kortmansky JS, Lacy J, Narang A, Herman J, Jabbour SK, Hallemeier CL, Johung K, Jethwa KR. Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national cancer database analysis. Clinical And Translational Radiation Oncology 2020, 27: 15-23. PMID: 33392398, PMCID: PMC7772693, DOI: 10.1016/j.ctro.2020.12.003.
Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under SurveillanceChhoda A, Yousaf MN, Madhani K, Aslanian H, Jamidar PA, Suarez AL, Salem R, Muniraj T, Kunstman J, Farrell JJ. Comorbidities Drive the Majority of Overall Mortality in Low-Risk Mucinous Pancreatic Cysts Under Surveillance. Clinical Gastroenterology And Hepatology 2020, 20: 631-640.e1. PMID: 33309984, DOI: 10.1016/j.cgh.2020.12.008.
Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cellsSiebenkäs C, Chiappinelli KB, Guzzetta AA, Sharma A, Jeschke J, Vatapalli R, Baylin SB, Ahuja N. Correction: Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells. PLOS ONE 2020, 15: e0243944. PMID: 33301506, PMCID: PMC7728177, DOI: 10.1371/journal.pone.0243944.
Abstract PO-015: Hypermethylated genes in leiomyosarcoma can be targeted through guadecitabine treatmentHasan N, De Carvalho Fischer C, Sharma A, Ahuja N. Abstract PO-015: Hypermethylated genes in leiomyosarcoma can be targeted through guadecitabine treatment. Cancer Research 2020, 80: po-015-po-015. DOI: 10.1158/1538-7445.epimetab20-po-015.
Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cellsSharma A, Vatapalli R, Abdelfatah E, McMahon KW, Kerner Z, A Guzzetta A, Singh J, Zahnow C, Baylin SB, Yerram S, Hu Y, Azad N, Ahuja N. Correction: Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells. PLOS ONE 2020, 15: e0242750. PMID: 33253231, PMCID: PMC7703978, DOI: 10.1371/journal.pone.0242750.
Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agentThakar M, Hu Y, Morreale M, Lerner L, Lin WY, Sen R, Cai Y, Karunasena E, Thakar M, Saggi S, Keer H, Ahuja N. Correction: A novel epigenetic modulating agent sensitizes pancreatic cells to a chemotherapy agent. PLOS ONE 2020, 15: e0242974. PMID: 33216806, PMCID: PMC7678985, DOI: 10.1371/journal.pone.0242974.

Download Full List